Robert L Hudkins
4PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 31, 2026
Structure-Based Design of a Novel Covalent 4-(1-Methylindol-3-yl)pyrimidin-2-amine Series Targeting FGFR2 Resistance Mutations.Robert L Hudkins, Eric Allen, Samhita Iyer
|Nov 03, 2025
Dabogratinib (TYRA-300), an FGFR3 Isoform-Selective Inhibitor: Preclinical and Initial Clinical Evidence of Antitumor Activity.Jacqueline H Starrett, Eric L Allen, Melissa Neal
|Oct 14, 2025
Dabogratinib (TYRA-300), an FGFR3 Isoform-Selective Inhibitor: Preclinical and Initial Clinical Evidence of Antitumor Activity.Jacqueline H Starrett, Eric L Allen, Melissa Neal
|Sep 11, 2024
Discovery of TYRA-300: First Oral Selective FGFR3 Inhibitor for the Treatment of Urothelial Cancers and Achondroplasia.Robert L Hudkins, Eric Allen, Alexandra Balcer
Pageof 1
Frequent Collaborators
2 joint publications
Isaac D Hoffman
2 joint publications
Kirk J Nelson
2 joint publications
Jacqueline H Starrett
2 joint publications
Eric L Allen
2 joint publications
Melissa Neal
2 joint publications
Samhita Iyer
2 joint publications
Qing Ye
2 joint publications
Viraj Degaonkar
2 joint publications
Christine Lihou
2 joint publications
Ronald V Swanson
